Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Post-Market Safety Data On Silicone-Gel Breast Implants May Prompt Labeling Changes

This article was originally published in The Gray Sheet

Executive Summary

Preliminary post-market safety data show that while silicone-gel-filled breast implants are safe, they “are not lifetime devices” and often have to be removed within 10 years, according to FDA device center Director Jeffrey Shuren.
Advertisement

Related Content

Breast Implant Makers Can Use Registries To Fulfill Post-Market Surveillance Duties
FDA Considers National Registry For Silicone Breast Implants
FDA Considers National Registry For Silicone Breast Implants
Regulatory News In Brief
Regulatory News In Brief
FDA Announces Possible Link Between Breast Implants And Cancer
FDA Announces Possible Link Between Breast Implants And Cancer
Advertisement
UsernamePublicRestriction

Register

MT030292

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel